Table 1.
Risk Factors Associated With Increased Morbidity and Mortality in Patients With Polycythemia Vera
Risk Factors |
---|
For thrombosis |
Age > 60 years |
Previous history of thrombosis |
Leukocytosis39–42* |
Increased JAK2 V617F allele burden6,43–45* |
High-risk gene expression profile46* |
For transformation to myelofibrosis or secondary acute myeloid leukemia |
Older age47 |
Longer disease duration48 |
Leukocytosis41 |
Exposure to phosphorus-32, pipobroman, or chlorambucil7,48 |
Risk factor associated with decreased survival |
Older age7 |
Leukocytosis7 |
History of venous thrombosis7 |
Abnormal karyotype7 |
Emerging or controversial risk factor.